Overview

RCT of CBD for Anxiety in Advanced Breast Cancer

Status:
Not yet recruiting
Trial end date:
2024-02-18
Target enrollment:
Participant gender:
Summary
This research study is investigating use of a single dose of cannabidiol (CBD) to help manage anticipatory anxiety in participants with advanced breast cancer poised to undergo computed tomography (CT) scan to assess tumor burden. The name of the study drug(s) are: - Cannabidiol (CBD)
Phase:
Phase 2
Details
Lead Sponsor:
Dana-Farber Cancer Institute
Collaborator:
Hans and Mavis Lopater Foundation
Treatments:
Cannabidiol
Epidiolex